In this episode, we dive into:
•
Dr. Feldman’s path to becoming a leader in biomarker and drug intelligence
•
The hottest trends in precision oncology and how they’re shaping the future
•
Game-changing studies at ASCO, including new targets like CLDN18
•
How molecular profiling is unlocking treatments for rare and hard-to-treat cancers
•
The rise of advanced therapies like bispecifics, ADCs, and smart drug combinations
•
The role of AI and blood-based diagnostics (ctDNA) in transforming clinical trials
•
How Caris is helping to expand trial access to underserved populations, including kids and patients with rare mutations
Plus, we get personal: Dr. Feldman shares what drives her, how she overcomes challenges, and her advice to women navigating careers in healthcare and health IT.
This episode is for anyone curious about where oncology is headed and how technology is helping to lead the way—with empathy, intelligence, and precision.